Felix Scheuplein
Blueprint Medicines (United States)
ORCID: 0000-0002-2691-0796Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 1 paper. Top paper: βCancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibodyβ.
8 citations
Peng Guan, Devika Bahal, Tanwir Hashem, Felix Scheuplein, Robert G. Schaub +3 more